Q3 2024 13F Holders as of 30 Sep 2024
-
Type / Class
-
Equity / Ordinary Shares, CHF 0.05 per share
-
Shares outstanding
-
67,372,245
-
Total 13F shares
-
17,872,624
-
Share change
-
-367
-
Total reported value
-
$65,159,858
-
Put/Call ratio
-
5.1%
-
Price per share
-
$3.65
-
Number of holders
-
30
-
Value change
-
-$395,953
-
Number of buys
-
12
-
Number of sells
-
11
Institutional Holders of SOPHiA GENETICS SA - Ordinary Shares, CHF 0.05 per share (SOPH) as of Q3 2024
As of 30 Sep 2024,
SOPHiA GENETICS SA - Ordinary Shares, CHF 0.05 per share (SOPH) was held by
30 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
17,872,624 shares.
The largest 10 holders included
GENERATION INVESTMENT MANAGEMENT LLP, BANQUE PICTET & CIE SA, AKRE CAPITAL MANAGEMENT LLC, UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC, PRINCIPAL FINANCIAL GROUP INC, Alta Wealth Advisors LLC, MILLENNIUM MANAGEMENT LLC, Bank Pictet & Cie (Europe) AG, EDMOND DE ROTHSCHILD HOLDING S.A., and GEODE CAPITAL MANAGEMENT, LLC.
This page lists
30
institutional shareholders reporting positions in this security
for the Q3 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.